Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Ipsen
Related studies linked through entity extraction aliases.
To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain
- Status
- COMPLETED
- Phase
- N/A
Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity
- Status
- COMPLETED
- Phase
- N/A
Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia
- Status
- COMPLETED
- Phase
- PHASE1
A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor
- Status
- RECRUITING
- Phase
- PHASE4
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- N/A
Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly
- Status
- TERMINATED
- Phase
- PHASE2
Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment Patterns and Treatment Outcomes for Acromegaly
- Status
- COMPLETED
- Phase
- N/A
Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity
- Status
- COMPLETED
- Phase
- N/A
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
- Status
- COMPLETED
- Phase
- N/A
To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Lanreotide in the Treatment of Small Bowel Motility Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)
- Status
- COMPLETED
- Phase
- PHASE4
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
- Status
- TERMINATED
- Phase
- PHASE2